NEW YORK (AP) — Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.
Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal
Related Posts
Johnson Level & Tool 40-6304 Multi-Function Mount for Rotary Lasers, 5/8″ Screw, Silver, 1 Mount
Tech CEO Bryan Johnson is spending millions to be 18 again, but a longevity expert says his ‘heroic discipline’ is unsustainable
